Development and comparison of three 89Zr-labeled anti-CLDN18.2 antibodies to noninvasively evaluate CLDN18.2 expression in gastric cancer: a preclinical studyGuilan Hu, Li Huo, Zheng Zhang et al.|European Journal of Nuclear Medicine and Molecular Imaging|2022Cited by 39
Correction to Design, Synthesis, and Antitumor Evaluation of Novel Histone Deacetylase Inhibitors Equipped with a Phenylsulfonylfuroxan Module as a Nitric Oxide DonorWenwen Duan, Yingjie Zhang, Jin Li et al.|Journal of Medicinal Chemistry|2015Cited by 3